Stopping Ozanimod: Large Trial Follow-Up Finds Relapses Return Mildly, With No Sign of Rebound
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod,...
Ophelia Keating is a Scienmag editorial specialist profile for Health Services Research coverage.
A large post hoc analysis of the DAYBREAK trial found that only 3.3 percent of patients relapsed after stopping ozanimod,...
A secondary analysis of the PATS randomized trial found that only 13 percent of children with mild sleep-disordered breathing worsened...
A new study in the Journal of Translational Medicine shows that the natural polyphenol piceatannol protects retinal blood vessels in...
A prospective study of eighteen patients with morphea found that ultrasound-measured dermal thickness significantly decreased with treatment, positioning high-frequency ultrasound...
Researchers in Kelantan, Malaysia have developed and statistically validated a 20-item Malay questionnaire measuring nurses' knowledge, attitudes, and preventive practices...
A CT study of 381 adults shows that the four zygomatic sutures have distinct geometric profiles, with small average side...
A four-year study of 2,630 Chinese adults with prediabetes found that the estimated glucose disposal rate predicted both progression to...
A qualitative study of 17 medical interpreters finds they perform eleven resilience-enhancing safety behaviors that current AI interpretation tools cannot...
A new study finds that a simple index combining triglycerides, total cholesterol, and body weight outperforms established nutritional tools in...
A retrospective real-world study from Milan's San Raffaele institute compares ocrelizumab and ofatumumab as successor therapies for multiple sclerosis patients...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine